Programmable Therapeutics Through Deterministic Logic

Moleculogic unifies Metal Drug Complexes (MDC), Functional Drug Complexes (FDC), and SEI-governed logic blueprints into a single platform for programmable medicine with unprecedented precision and control.

Logic: MITF upregulation
Target: Hair follicle regeneration
Tier: 2 (Validated)

Blueprint Spotlight

ID: GRX-REGEN-χ1

Type: FDC Logic Blueprint

Target: Hair graying reversal

Mechanism: Stem cell regeneration

Entropy: Low

What Sets Us Apart

Most platforms guess. We build structured simulations based on interaction logic across redox states, pH variations, and electrostatic dynamics. Every outcome can be traced back to logical blueprints.

Blueprint Formalism

JSON/SYW encoded, hashed, auditable blueprints. Every molecule has a traceable logic structure you can verify.

Anti-Failure Design

Known toxicities encoded as exclusion vectors. Failure modes become input data for safer design iterations.

Entropy Logic

Every blueprint has entropy class and drift forecast. Predictable behavior with measurable uncertainty bounds.

Tiered Simulations

Access controlled simulation environments with increasing capabilities as you progress through verification tiers.

Ethical Guidelines

Built-in safety protocols and ethical frameworks ensure responsible molecular design and simulation.

Rule Library Inheritance

Built on established coordination chemistry and biological logic rules, extending proven frameworks safely.

Ask Moleculogic

Curious how logic shapes therapeutics? Start a conversation with the Moleculogic Engine. Ask a scientific question, propose a condition, or explore live blueprints.

Preview a recent multi-tier interaction:

User: Can Moleculogic design a Treg therapy that avoids IL-2 mutein toxicity?

Engine: Yes. I propose FDC-TREGBAL-χ1, governed by IL-2Rα bias and Foxp3 overlay logic. Predicted confidence: 89%, entropy: moderate. Blueprint hash available via Tier 1 access.

Clinical Pipeline in Development

From Tier 2 validated blueprints to Tier 4 clinical candidates, discover our expanding therapeutic pipeline powered by deterministic logic.

Tier 4 Clinical Ready

Redunera

Advanced renal therapeutic with validated Tier 4 logic framework

Status: Pre-clinical validation

Tier 3 Optimized

Ru⁴⁺-Doxorubicin

Metal-guided oncology complex with enhanced selectivity

Status: Lead optimization

Tier 2 Validated

GRX-REGEN-χ1

Hair follicle regeneration via MITF upregulation logic

Status: Mechanism validation

Core Technologies

Explore our integrated platforms for molecular design, simulation, and validation

Metal Drug Complex (MDC)

Coordination-driven therapeutic design leveraging metal-ligand interactions for programmable drug behavior.

  • pH and redox responsive activation
  • Logic-gated therapeutic delivery
  • Advanced metal coordination chemistry
Explore MDC Platform

Functional Drug Complex (FDC)

Biologically-guided simulation for peptide, RNA, and ligand-based therapeutic programming.

  • Peptide-RNA programmable modules
  • Conditional activation pathways
  • Glyco-tagged delivery systems
Explore FDC Platform

Moleculogic Simulation Platform

Our unified simulation environment powers both MDC and FDC frameworks with logic-driven modeling, validation, and blueprint generation through SEI-governed deterministic processes.

  • Blueprint serialization with hash verification
  • Entropy overlay and simulation control
  • Tiered access with secure verification
Explore Moleculogic

Resources & Documentation

Explore these key resources to understand our platform's capabilities and access options

Access Tiers

Understand our tiered access model, from public preview to secure co-development environments.

Learn More

Moleculogic Discovery

Explore daily generated molecular blueprints from our Moleculogic Engine Discovery system.

View Blueprint Feed

Clinical Pipeline

Discover our current therapeutic candidates and their development status across various indications.

View Pipeline

Publications

Access our published papers, research findings, and request review access to latest developments.

Browse Publications

Licensing Opportunities

Explore flexible licensing models, from drug-by-drug to platform-as-a-service options.

Licensing Options

Ethical Simulation Policy

Learn about our commitment to ethical molecular design and controlled simulation environments.

Ethics Framework

Moleculogic Discovery

Explore daily generated molecular blueprints from our Moleculogic Engine Discovery system. Get insights into novel therapeutic concepts and molecular designs created through deterministic reasoning.

View SEI Blueprint Feed

Latest Blueprints

Updated Daily

MDC Logic Concepts

FDC Therapeutic Designs

Who We Serve

MetalDrug partners with organizations across the therapeutic development spectrum

Biopharma Companies

From discovery to clinical development, we provide infrastructure to validate and co-develop compounds through tiered logic licensing.

Academic Researchers

Auditable simulation for researchers needing logic testing, compound optimization, or grant-ready infrastructure across therapeutic classes.

Biotech Startups

Blueprint leasing and startup-friendly licensing models for rapid proof-of-concept generation using our simulation infrastructure.

Get Access to Tier 1 Logic Simulations

Request access to advanced blueprint validation and programmable molecular testing via our secure logic interface. Designed for scientific clarity, regulatory alignment, and innovation at the frontier.